Rehovot, Israel

Boris Schwartsburd

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Boris Schwartsburd

Introduction

Boris Schwartsburd is a notable inventor based in Rehovot, Israel, recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of four patents to his name, he has made strides in developing liquid formulations that hold promise for improved medical treatments.

Latest Patents

Among Boris Schwartsburd's latest inventions are patents focusing on liquid pharmaceutical compositions that incorporate mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugates. These formulations are designed for use in prefilled syringes or autoinjectors, potentially enhancing the delivery and efficacy of therapeutic applications. The patents emphasize innovative solutions for creating liquid formulations that can improve the handling and administration of pharmaceutical compounds.

Career Highlights

Boris has worked with reputable organizations in the pharmaceutical industry, including 89bio, Inc. and Laboratoires Serono S.A. His experience in these companies has equipped him with a robust understanding of the complexities involved in pharmaceutical development and innovation.

Collaborations

Throughout his career, Boris has collaborated with other talented professionals in the field. Notable among his coworkers are Shaji Joseph and Ilana Belzer, who have contributed to the research and development initiatives that underlie his patents.

Conclusion

Boris Schwartsburd continues to make impactful contributions to the pharmaceutical industry through his innovative work on mutant FGF-21 peptide conjugates. His patents reflect a commitment to advancing medical technology and improving patient care, which is commendable in the ever-evolving landscape of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…